Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director
Vancouver, British Columbia, September 22, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX) (“GENIX” or…
Genix Pharmaceuticals Corporation Announces Closing of Second Tranche Financing and closing of acquisition of rights to Nutraceutical Products Sucanon® and Renochlor®
VANCOUVER, BRITISH COLUMBIA, August 6, 2020 — Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA, July 17, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX)…
Genix Pharmaceuticals Corporation Announces the Extension of Payment Terms for the Acquisitions of Rights to Renochlor®, Sucanon® and Flu-x™
VANCOUVER, BRITISH COLUMBIA, June 30, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX) (“GENIX”…
Genix Pharmaceuticals Corporation Announces Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA, June 22, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX)…
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
DGAP-News: Genix Pharmaceuticals Corp. / Key word(s): Miscellaneous Genix Pharmaceuticals…